A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome

Abstract Background Persistent Müllerian duct syndrome (PMDS) is defined as the presence of Müllerian duct derivatives in an otherwise normally virilized 46, XY male. It is usually caused by homozygous or compound heterozygous mutations in either the anti‐Müllerian hormone (AMH) or AMH receptor type...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jianzheng Fang, Gao Gao, Jinyong Liu, Lingbo Cai, Yugui Cui, Xiaoyu Yang
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/62bdb091c8f64a2e938dd811d41609a5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:62bdb091c8f64a2e938dd811d41609a5
record_format dspace
spelling oai:doaj.org-article:62bdb091c8f64a2e938dd811d41609a52021-11-10T16:39:24ZA novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome2324-926910.1002/mgg3.1801https://doaj.org/article/62bdb091c8f64a2e938dd811d41609a52021-10-01T00:00:00Zhttps://doi.org/10.1002/mgg3.1801https://doaj.org/toc/2324-9269Abstract Background Persistent Müllerian duct syndrome (PMDS) is defined as the presence of Müllerian duct derivatives in an otherwise normally virilized 46, XY male. It is usually caused by homozygous or compound heterozygous mutations in either the anti‐Müllerian hormone (AMH) or AMH receptor type 2 (AMHR2) genes. The main purpose of the study is to determine the novel mutations of AMHR2 in PMDS patients and their intracytoplasmic sperm injection outcomes (ICSI). Methods Whole‐exome sequencing (WES) was carried out. Sanger sequencing was used to detect mutations in AMHR2. The pathogenicity of the identified variant and its possible effects on the protein were evaluated with in silico tools. The expression level of AMHR2 was determined by Western blotting. The spermatogenic function was evaluated by testicular sperm aspiration and histopathologic examination. The ICSI outcomes were recorded. Results We present two brothers with a history of bilateral cryptorchidism with orchidopexy and infertility due to azoospermia. A novel compound heterozygous mutation of c.1219C>T [p.R407X] and c.1387C>T [p.R463C] in exons 9 and 10 of AMHR2 (NM_020547.2) was detected by whole‐exome sequencing (WES). Spermatozoon could be retrieved from the two patients by testicular aspiration following intracytoplasmic sperm injection (ICSI) due to azoospermia. Finally, patient 1 had two healthy boys and patient 2 failed to conceive after three ICSI attempts. Conclusion The spermatozoa could obtain from PMDS patients due to azoospermia. For patients with bilateral cryptorchidism, PMDS should be included in the differential diagnosis and that genetic counseling needs to be considered when they seek reproductive help.Jianzheng FangGao GaoJinyong LiuLingbo CaiYugui CuiXiaoyu YangWileyarticleAMH receptor type 2cryptorchidismintracytoplasmic sperm injection (ICSI)mutationPersistent Müllerian duct syndromeGeneticsQH426-470ENMolecular Genetics & Genomic Medicine, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic AMH receptor type 2
cryptorchidism
intracytoplasmic sperm injection (ICSI)
mutation
Persistent Müllerian duct syndrome
Genetics
QH426-470
spellingShingle AMH receptor type 2
cryptorchidism
intracytoplasmic sperm injection (ICSI)
mutation
Persistent Müllerian duct syndrome
Genetics
QH426-470
Jianzheng Fang
Gao Gao
Jinyong Liu
Lingbo Cai
Yugui Cui
Xiaoyu Yang
A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
description Abstract Background Persistent Müllerian duct syndrome (PMDS) is defined as the presence of Müllerian duct derivatives in an otherwise normally virilized 46, XY male. It is usually caused by homozygous or compound heterozygous mutations in either the anti‐Müllerian hormone (AMH) or AMH receptor type 2 (AMHR2) genes. The main purpose of the study is to determine the novel mutations of AMHR2 in PMDS patients and their intracytoplasmic sperm injection outcomes (ICSI). Methods Whole‐exome sequencing (WES) was carried out. Sanger sequencing was used to detect mutations in AMHR2. The pathogenicity of the identified variant and its possible effects on the protein were evaluated with in silico tools. The expression level of AMHR2 was determined by Western blotting. The spermatogenic function was evaluated by testicular sperm aspiration and histopathologic examination. The ICSI outcomes were recorded. Results We present two brothers with a history of bilateral cryptorchidism with orchidopexy and infertility due to azoospermia. A novel compound heterozygous mutation of c.1219C>T [p.R407X] and c.1387C>T [p.R463C] in exons 9 and 10 of AMHR2 (NM_020547.2) was detected by whole‐exome sequencing (WES). Spermatozoon could be retrieved from the two patients by testicular aspiration following intracytoplasmic sperm injection (ICSI) due to azoospermia. Finally, patient 1 had two healthy boys and patient 2 failed to conceive after three ICSI attempts. Conclusion The spermatozoa could obtain from PMDS patients due to azoospermia. For patients with bilateral cryptorchidism, PMDS should be included in the differential diagnosis and that genetic counseling needs to be considered when they seek reproductive help.
format article
author Jianzheng Fang
Gao Gao
Jinyong Liu
Lingbo Cai
Yugui Cui
Xiaoyu Yang
author_facet Jianzheng Fang
Gao Gao
Jinyong Liu
Lingbo Cai
Yugui Cui
Xiaoyu Yang
author_sort Jianzheng Fang
title A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_short A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_full A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_fullStr A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_full_unstemmed A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_sort novel mutation of amhr2 in two brothers with persistent müllerian duct syndrome and their intracytoplasmic sperm injection outcome
publisher Wiley
publishDate 2021
url https://doaj.org/article/62bdb091c8f64a2e938dd811d41609a5
work_keys_str_mv AT jianzhengfang anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT gaogao anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT jinyongliu anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT lingbocai anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT yuguicui anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT xiaoyuyang anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT jianzhengfang novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT gaogao novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT jinyongliu novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT lingbocai novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT yuguicui novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT xiaoyuyang novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
_version_ 1718439873151500288